Literature DB >> 24109243

Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-κB activation.

Frances W Lai1, Kyle B Stephenson, James Mahony, Brian D Lichty.   

Abstract

The human coronavirus OC43 is a major contributor to the common cold worldwide, though due to its low mortality rate, little research has focused on this human pathogen. The nucleocapsid is an essential structural protein with conserved functions across the coronavirus family. While a multitude of studies have examined nucleocapsid function, none have described the effects of OC43 nucleocapsid on the transcription factor NF-κB. We report that the nucleocapsid protein of OC43 causes potentiation of NF-κB activation. This prolonged activation is the direct result of the ability of the nucleocapsid to bind RNA, specifically microRNA 9 (miR-9), which is a negative regulator of NF-κB. This previously undescribed interaction between virus and host is a potential mechanism of immune evasion in RNA viruses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24109243      PMCID: PMC3911702          DOI: 10.1128/JVI.02678-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus.

Authors:  J A Hiscox; T Wurm; L Wilson; P Britton; D Cavanagh; G Brooks
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

3.  Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB.

Authors:  Wei-Chien Huang; Tsai-Kai Ju; Mien-Chie Hung; Ching-Chow Chen
Journal:  Mol Cell       Date:  2007-04-13       Impact factor: 17.970

Review 4.  MicroRNAs: the fine-tuners of Toll-like receptor signalling.

Authors:  Luke A O'Neill; Frederick J Sheedy; Claire E McCoy
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

5.  The localization of porcine reproductive and respiratory syndrome virus nucleocapsid protein to the nucleolus of infected cells and identification of a potential nucleolar localization signal sequence.

Authors:  R R Rowland; R Kervin; C Kuckleburg; A Sperlich; D A Benfield
Journal:  Virus Res       Date:  1999-10       Impact factor: 3.303

6.  The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner.

Authors:  Anu K Moorthy; Olga V Savinova; Jessica Q Ho; Vivien Ya-Fan Wang; Don Vu; Gourisankar Ghosh
Journal:  EMBO J       Date:  2006-04-13       Impact factor: 11.598

7.  Biosynthesis and biochemical properties of the hepatitis C virus core protein.

Authors:  E Santolini; G Migliaccio; N La Monica
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling.

Authors:  Matthew Frieman; Kiira Ratia; Robert E Johnston; Andrew D Mesecar; Ralph S Baric
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

9.  An outbreak of coronavirus OC43 respiratory infection in Normandy, France.

Authors:  Astrid Vabret; Thomas Mourez; Stéphanie Gouarin; Joëlle Petitjean; François Freymuth
Journal:  Clin Infect Dis       Date:  2003-04-04       Impact factor: 9.079

10.  The nucleocapsid protein of SARS-associated coronavirus inhibits B23 phosphorylation.

Authors:  Yingchun Zeng; Linbai Ye; Shengli Zhu; Hong Zheng; Peng Zhao; Weijia Cai; Liya Su; Yinglong She; Zhenghui Wu
Journal:  Biochem Biophys Res Commun       Date:  2008-02-01       Impact factor: 3.575

View more
  35 in total

Review 1.  Non-Invasive Colorectal Cancer Screening: An Overview.

Authors:  Melanie Tepus; Tung On Yau
Journal:  Gastrointest Tumors       Date:  2020-05-20

Review 2.  Human Coronaviruses: A Review of Virus-Host Interactions.

Authors:  Yvonne Xinyi Lim; Yan Ling Ng; James P Tam; Ding Xiang Liu
Journal:  Diseases       Date:  2016-07-25

3.  miR-21a-5p Contributes to Porcine Hemagglutinating Encephalomyelitis Virus Proliferation via Targeting CASK-Interactive Protein1 In vivo and vitro.

Authors:  Xiaoling Lv; Kui Zhao; Yungang Lan; Zi Li; Ning Ding; Jingjing Su; Huijun Lu; Deguang Song; Feng Gao; Wenqi He
Journal:  Front Microbiol       Date:  2017-03-01       Impact factor: 5.640

Review 4.  MicroRNA Regulation of RNA Virus Replication and Pathogenesis.

Authors:  Derek W Trobaugh; William B Klimstra
Journal:  Trends Mol Med       Date:  2016-12-16       Impact factor: 11.951

Review 5.  The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.

Authors:  David G Maranon; John R Anderson; Abril G Maranon; Jeffrey Wilusz
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-07-07       Impact factor: 9.957

6.  Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.

Authors:  Ali Hosseini Rad Sm; Alexander D McLellan
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

Review 7.  The coronavirus nucleocapsid is a multifunctional protein.

Authors:  Ruth McBride; Marjorie van Zyl; Burtram C Fielding
Journal:  Viruses       Date:  2014-08-07       Impact factor: 5.048

8.  Early events during human coronavirus OC43 entry to the cell.

Authors:  Katarzyna Owczarek; Artur Szczepanski; Aleksandra Milewska; Zbigniew Baster; Zenon Rajfur; Michal Sarna; Krzysztof Pyrc
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

Review 9.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694

Review 10.  The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.

Authors:  Jiulue Hu; Jelena Stojanović; Saman Yasamineh; Pooneh Yasamineh; Sathish Kumar Karuppannan; Mohammed Junaid Hussain Dowlath; Hamed Serati-Nouri
Journal:  Arch Virol       Date:  2021-07-19       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.